157 related articles for article (PubMed ID: 20978193)
1. Serum vitamin D and risk of bladder cancer.
Mondul AM; Weinstein SJ; Männistö S; Snyder K; Horst RL; Virtamo J; Albanes D
Cancer Res; 2010 Nov; 70(22):9218-23. PubMed ID: 20978193
[TBL] [Abstract][Full Text] [Related]
2. Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer.
Mondul AM; Weinstein SJ; Virtamo J; Albanes D
Br J Cancer; 2012 Oct; 107(9):1589-94. PubMed ID: 22990651
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
[TBL] [Abstract][Full Text] [Related]
4. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
[TBL] [Abstract][Full Text] [Related]
5. Serum vitamin D, vitamin D binding protein, and lung cancer survival.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
Lung Cancer; 2014 Dec; 86(3):297-303. PubMed ID: 25456734
[TBL] [Abstract][Full Text] [Related]
6. Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial.
Mondul AM; Weinstein SJ; Horst RL; Purdue M; Albanes D
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1222-5. PubMed ID: 22623707
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.
Hektoen HH; Robsahm TE; Stenehjem JS; Axcrona K; Babigumira R; Mondul AM; Gislefoss RE; Andreassen BK
Cancer Med; 2021 Jun; 10(12):4107-4116. PubMed ID: 34080787
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men.
Weinstein SJ; Yu K; Horst RL; Ashby J; Virtamo J; Albanes D
Am J Epidemiol; 2011 Mar; 173(5):499-508. PubMed ID: 21248311
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
[TBL] [Abstract][Full Text] [Related]
10. Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC Study.
Lai GY; Wang JB; Weinstein SJ; Parisi D; Horst RL; McGlynn KA; Männistö S; Albanes D; Freedman ND
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1075-1082. PubMed ID: 29720370
[No Abstract] [Full Text] [Related]
11. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
12. Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers.
Malila N; Virtamo J; Virtanen M; Pietinen P; Albanes D; Teppo L
Eur J Clin Nutr; 2002 Jul; 56(7):615-21. PubMed ID: 12080400
[TBL] [Abstract][Full Text] [Related]
13. Supplementation with alpha-tocopherol or beta-carotene reduces serum concentrations of vascular endothelial growth factor-D, but Not -A or -C, in male smokers.
Mondul AM; Rager HC; Kopp W; Virtamo J; Albanes D
J Nutr; 2011 Nov; 141(11):2030-4. PubMed ID: 21956960
[TBL] [Abstract][Full Text] [Related]
14. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087
[TBL] [Abstract][Full Text] [Related]
15. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.
Lim U; Freedman DM; Hollis BW; Horst RL; Purdue MP; Chatterjee N; Weinstein SJ; Morton LM; Schatzkin A; Virtamo J; Linet MS; Hartge P; Albanes D
Int J Cancer; 2009 Feb; 124(4):979-86. PubMed ID: 19035445
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Nelson SM; Panagiotou OA; Anic GM; Mondul AM; Männistö S; Weinstein SJ; Albanes D
Int J Epidemiol; 2016 Oct; 45(5):1458-1468. PubMed ID: 27524818
[TBL] [Abstract][Full Text] [Related]
17. β-Carotene Supplementation and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: The Role of Tar and Nicotine.
Middha P; Weinstein SJ; Männistö S; Albanes D; Mondul AM
Nicotine Tob Res; 2019 Jul; 21(8):1045-1050. PubMed ID: 29889248
[TBL] [Abstract][Full Text] [Related]
18. Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women.
Cheng TD; Song X; Beresford SAA; Ho GYF; Johnson KC; Datta M; Chlebowski RT; Wactawski-Wende J; Qi L; Neuhouser ML
Cancer Causes Control; 2017 Oct; 28(10):1053-1063. PubMed ID: 28900765
[TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.
Arem H; Weinstein SJ; Horst RL; Virtamo J; Yu K; Albanes D; Abnet CC
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1178-84. PubMed ID: 21527582
[TBL] [Abstract][Full Text] [Related]
20. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
Goodman GE; Schaffer S; Omenn GS; Chen C; King I
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
